Results: A 24 h exposure to estramustine (<= 100 mu M) significantly increased [Ca2+](i), increased

annexin V binding and increased hemoglobin release. The effect of estramustine on annexin V binding was significantly blunted by removal of extracellular Ca2+. Conclusions: Estramustine stimulates both, eryptosis and hemolysis. The estramustine induced translocation of phosphatidylserine to the cell surface is at least partially due to increase of cytosolic Ca2+ activity. Copyright (C) NCT-501 2013 S. Karger AG, Basel”
“Objective: This study aims to assess potential complications of autologous lymph-node transplantation (ALNT) to treat limb lymphoedema.\n\nDesign: Prospective, observational study.\n\nMethod: All limb-lymphoedema patients, followed up in Salubrinal in vitro a single lymphology department, who decided to undergo ALNT (January 2004-June 2012) independently of our medical team, were included.\n\nResults: Among the 26 patients (22 females, four males) included, 14 had secondary upper-limb lymphoedenna after breast-cancer treatment and seven had secondary and five primary lower-limb lymphoedema. Median (interquartile range, IQR) ages at primary lower-limb lymphoedema and secondary lymphoedema onset were 18.5 (13-30) and 47.4 (35-58) years, respectively.

Median body mass index (BMI) was 25.9 (22.9-29.3) kg m(-2). For all patients, median pre-surgery lymphoedema duration was 37 (24-90) months. Thirty-four ALNs were transplanted into the 26 patients, combined with liposuction in four lower-limb-lymphoedema patients. Ten

(38%) patients developed 15 complications: six, chronic lymphoedema (four upper limb, two lower limb), defined as >= 2-cm difference versus the contralateral side, in the limb on the donor lymph-node-site territory, persisting for a median of 40 months post-ALNT; four, post-surgical lymphocoeles; one testicular hydrocoele requiring surgery; and four with persistent donor-site pain. Median see more (IQR) pre- and post-surgical lymphoedema volumes, calculated using the formula for a truncated cone, were, respectively, 1023 (633-1375) ml (median: 3 (1-6) months) and 1058 (666-1506) ml (median: 40 (14-72) months; P = 0.73).\n\nConclusion: ALNT may engender severe, chronic complications, particularly persistent iatrogenic lymphoedema. Further investigations are required to evaluate and clearly determine its indications. (C) 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.”
“Although islet transplantation has demonstrated its potential use in treating type 1 diabetes, this remains limited by the need for daily immunosuppression. Islet encapsulation was then proposed with a view to avoiding any immunosuppressive regimen and related side effects.